查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830800

2025年介入性腫瘤學全球市場報告

Interventional Oncology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，介入性腫瘤學市場規模強勁成長，從2024年的24.9億美元增加至2025年的27.2億美元，複合年成長率達9.2%。這段時期的成長可歸因於全球癌症發生率的上升、微創手術的普及、新興國家醫療保健支出的增加、對影像引導手術的需求不斷成長，以及人們對介入腫瘤學益處的認知不斷提高。

預計未來幾年介入腫瘤學市場將強勁成長，到2029年將達到38.2億美元，複合年成長率為8.8%。預測期內的成長歸因於門診腫瘤治療需求的不斷成長、聯合治療與免疫腫瘤學應用的不斷增加、影像引導治療臨床試驗的擴展、新興市場介入腫瘤學可及性的提升，以及精準醫療在治療計劃中日益重要的作用。預測期內的主要趨勢包括影像導引消融技術的進步、人工智慧診斷工具的發展、標靶給藥系統的創新、微創治療設備的進步以及個人化腫瘤治療方案的出現。

介入性腫瘤學是一門專注於利用微創影像引導技術診斷和治療癌症的醫學專業。其主要目標是提供有效的癌症治療，相比傳統手術方法，其恢復時間更短，副作用更少。

介入性腫瘤學設備的主要類型包括放射治療設備、消融設備和栓塞設備。放射治療設備是專門設計的機器，用於將精確劑量的電離輻射傳送到體內的目標區域，目的是摧毀或損傷異常細胞，同時最大限度地減少對周圍健康組織的傷害。這些設備採用超音波、電腦斷層掃描 (CT) 引導和磁振造影(MRI) 引導等技術。使用這些設備執行的程序包括腫瘤切除、腫瘤切片檢查、血管介入和安寧療護。這些治療適用於多種癌症，包括肝癌、肺癌、腎癌、胰腺癌和前列腺癌，並服務於各種最終用戶，包括醫院、門診手術中心、專科診所以及研究和學術機構。

2025年春季美國突然提高關稅以及由此引發的貿易摩擦嚴重影響了醫療保健產業，尤其是關鍵醫療設備、診斷設備和藥品的供應。醫院和醫療機構面臨進口手術器械、影像設備以及注射器和導管等消耗品成本上漲的問題。這些成本上漲給醫療保健預算帶來了巨大壓力，導致一些醫療機構推遲設備升級或將成本轉嫁給患者。此外，原料和零件的關稅阻礙了基本藥品和醫療設備的生產，造成供應鏈瓶頸。作為應對措施，該行業正在使其籌資策略多樣化，盡可能促進本地生產，並倡導緊急醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供介入腫瘤學市場統計數據，例如全球市場規模、區域佔有率、介入腫瘤學市場佔有率的競爭對手、詳細的介入腫瘤學細分市場、市場趨勢和商業機會，以及您在介入腫瘤學行業取得成功所需的數據。本介入性腫瘤學市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，以完整的觀點為您提供所需的所有資訊。

預計未來幾年癌症盛行率的上升將推動介入腫瘤學市場的成長。癌症盛行率是指在總合時間內新診斷出癌症的人數加上先前診斷出的人數。癌症患者數量的增加主要是由於生活方式相關的風險因素，例如不良飲食、吸煙、飲酒和接觸環境污染物。介入性腫瘤學透過提供直接針對腫瘤的微創標靶治療來支持癌症治療。與傳統治療方法相比，這些方法透過減少對健康組織的傷害和加速復原來改善患者的預後。例如，根據澳洲政府機構澳洲健康與福利研究所的數據，截至 2024 年 7 月，2022 年澳洲診斷出的癌症患者為 160,570 人，比 2021 年的 156,781 人增加了 3,789 人。因此，癌症盛行率的上升正在推動介入腫瘤學市場的擴張。

介入腫瘤學市場的公司正在開發先進技術，例如基於微導管的栓塞系統，以實現高度精確和有針對性的癌症治療，同時最大限度地減少對周圍健康組織的損害。以微導管為基礎的栓塞系統使用小型軟性導管將栓塞劑直接輸送到血管中，阻斷或減少血流。它們通常用於醫療設備腫瘤、血管畸形和出血。例如，2025 年 3 月，日本醫療設備製造商Terumo Corporation推出了 Occlusafe 球囊閉塞導管，作為肝癌（特別是肝細胞癌 (HCC)）球囊 TACE (B-TACE) 治療的一部分。這種專用微導管利用壓力梯度效應來改變血流方向並進入微循環，從而能夠將更高濃度的治療劑輸送到腫瘤部位，同時最大限度地減少脫靶栓塞。這種有針對性的方法旨在透過提高藥物輸送的精確度和改善手術過程中的可視性來改善棘手肝癌病例的臨床結果。

2022年8月，美國醫療設備製造商波士頓科學公司（Boston Scientific）收購了Obsidio，具體金額未揭露。透過此次收購，波士頓科學公司希望透過整合獨特的栓塞技術來擴大其介入性腫瘤學和栓塞治療產品組合，從而提高手術效率並實現個人化治療。 Obsidio是一家總部位於美國的公司，專注於創新的介入性腫瘤學解決方案。

介入性腫瘤學市場包括提供影像導引腫瘤切除、切片檢查和診斷影像、疼痛緩解程序以及熱消融計劃和追蹤等服務的營業單位所獲得的收益。市場價值還包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。介入腫瘤學市場還包括影像引導導航系統、導管和導管導引線、放射輸送系統以及切片穿刺針和系統的銷售。這代表產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品的價值。該市場中的產品價值還包括產品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球介入性腫瘤學：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球介入性腫瘤學市場：成長率分析
  • 全球介入性腫瘤學市場表現：規模與成長，2019-2024
  • 全球介入性腫瘤學市場預測：2024-2029年及2034年規模與成長
  • 全球介入性腫瘤學：總目標市場（TAM）

第6章 市場細分

  • 全球介入性腫瘤學市場：依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 放射治療設備
  • 消融設備
  • 栓塞裝置
  • 全球介入性腫瘤學市場（按技術類型分類）：實際值和預測值，2019-2024 年、2024-2029 年、2034 年
  • 超音波
  • CT引導下
  • 磁共振感應
  • 全球介入性腫瘤學市場（按程序、實際情況和預測），2019-2024 年、2024-2029 年、2034 年
  • 腫瘤消融
  • 腫瘤切片檢查
  • 血管介入
  • 安寧療護
  • 全球介入性腫瘤學市場的應用、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 肝癌
  • 肺癌
  • 腎癌
  • 胰臟癌
  • 攝護腺癌
  • 全球介入性腫瘤學市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 專科診所
  • 研究和學術機構
  • 全球介入性腫瘤學市場：放射治療設備細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 線性加速器
  • 質子治療系統
  • 近距離放射治療裝置
  • 全球介入性腫瘤學市場：按消融設備類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 射頻消融術裝置
  • 微波消融裝置
  • 冷凍消融裝置
  • 不可逆電穿孔系統
  • 全球介入性腫瘤學市場：按栓塞裝置細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 微球
  • 線圈栓塞裝置
  • 液態栓塞劑
  • 栓塞保護裝置

第7章 區域和國家分析

  • 全球介入性腫瘤學市場：區域表現與預測，2019-2024 年、2024-2029 年、2034 年
  • 全球介入性腫瘤學市場：各國表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 介入性腫瘤學市場：競爭格局
  • 介入性腫瘤學市場：公司簡介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Terumo Corporation
  • Hologic Inc.
  • Teleflex Incorporated
  • Lantheus Holdings Inc.
  • Penumbra Inc.
  • Merit Medical Systems Inc.
  • Guerbet SA
  • Asahi Intecc Co. Ltd.
  • AngioDynamics Inc.
  • Sirtex Medical Limited.
  • Delcath Systems Inc.
  • ABK Biomedical Inc.
  • Profound Medical Inc.
  • IceCure Medical Ltd.
  • Minimax Medical Holding Group

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年介入腫瘤學市場：提供新機會的國家
  • 2029年介入腫瘤學市場：細分領域帶來新機會
  • 2029年介入腫瘤學市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37789

Interventional oncology is a medical specialty that focuses on minimally invasive, image-guided procedures for the diagnosis and treatment of cancer. Its primary goal is to provide effective cancer therapies with shorter recovery times and fewer side effects compared to traditional surgical approaches.

The primary types of interventional oncology include radiation therapy devices, ablation devices, and embolization devices. Radiation therapy devices are specialized equipment designed to deliver precise doses of ionizing radiation to targeted areas in the body, aiming to destroy or damage abnormal cells while minimizing harm to surrounding healthy tissue. These devices employ technologies such as ultrasound, computed tomography (CT) guidance, and magnetic resonance imaging (MRI) guidance. Procedures performed using these devices include tumor ablation, tumor biopsy, vascular interventions, and palliative care. These treatments are applied to various cancers, including liver, lung, kidney, pancreatic, and prostate cancers, and serve a range of end-users such as hospitals, ambulatory surgical centers, specialty clinics, and research and academic institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The interventional oncology market research report is one of a series of new reports from The Business Research Company that provides interventional oncology market statistics, including interventional oncology industry global market size, regional shares, competitors with an interventional oncology market share, detailed interventional oncology market segments, market trends and opportunities, and any further data you may need to thrive in the interventional oncology industry. This interventional oncology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The interventional oncology market size has grown strongly in recent years. It will grow from $2.49 billion in 2024 to $2.72 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth during the historic period can be attributed to the rising incidence of cancer globally, increased adoption of minimally invasive procedures, growing healthcare expenditure in emerging economies, higher demand for image-guided therapies, and heightened awareness of the benefits of interventional oncology.

The interventional oncology market size is expected to see strong growth in the next few years. It will grow to $3.82 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth during the forecast period can be attributed to the rising demand for outpatient oncology procedures, increased use of combination therapies with immuno-oncology, expanding clinical trials for image-guided therapies, greater access to interventional oncology in emerging markets, and the growing role of precision medicine in treatment planning. Major trends expected in the forecast period include advancements in image-guided ablation technologies, development of AI-powered diagnostic tools, innovations in targeted drug-delivery systems, progress in minimally invasive treatment devices, and the emergence of personalized oncology treatment solutions.

The rising prevalence of cancer is expected to drive growth in the interventional oncology market in the coming years. Cancer prevalence refers to the total number of individuals, both newly and previously diagnosed, who are living with a history of cancer at a given point in time. The increase in cancer cases is largely attributed to lifestyle-related risk factors such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, which elevate the likelihood of developing various cancers. Interventional oncology supports cancer treatment by offering minimally invasive, targeted therapies that directly focus on tumors. These approaches enhance patient outcomes by reducing harm to healthy tissue and providing faster recovery compared to conventional treatments. For example, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, 160,570 cancer cases were diagnosed in Australia in 2022, representing an increase of 3,789 cases from 156,781 in 2021. Therefore, the growing prevalence of cancer is propelling the expansion of the interventional oncology market.

Companies in the interventional oncology market are developing advanced technologies, such as microcatheter-based embolization systems, to deliver highly precise, targeted cancer therapy while minimizing damage to surrounding healthy tissue. Microcatheter-based embolization systems are medical devices that use small, flexible catheters to deliver embolic agents directly into blood vessels to block or reduce blood flow, typically for the treatment of tumors, vascular malformations, or bleeding. For instance, in March 2025, Terumo Corporation, a Japan-based medical device company, introduced the Occlusafe balloon occlusion catheter as part of its Balloon-TACE (B-TACE) therapy for liver cancer, particularly hepatocellular carcinoma (HCC). This specialized microcatheter utilizes the pressure gradient effect to redirect blood flow and access the microcirculation, allowing higher concentrations of therapeutic agents at the tumor site while minimizing off-target embolization. This targeted method aims to improve clinical outcomes in challenging liver cancer cases by enhancing drug delivery accuracy and providing better visualization during procedures.

In August 2022, Boston Scientific Corporation, a US-based medical device company, acquired Obsidio Inc. for an undisclosed sum. Through this acquisition, Boston Scientific seeks to expand its interventional oncology and embolization portfolio by integrating a distinctive embolic technology that enhances procedural efficiency and enables personalized therapy for patients. Obsidio Inc. is a US-based company specializing in innovative interventional oncology solutions.

Major players in the interventional oncology market are Johnson & Johnson, Siemens Healthineers AG, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Hologic Inc., Teleflex Incorporated, Lantheus Holdings Inc., Penumbra Inc., Merit Medical Systems Inc., Guerbet S.A, Asahi Intecc Co. Ltd., AngioDynamics Inc., Sirtex Medical Limited., Delcath Systems Inc., ABK Biomedical Inc., Profound Medical Inc., IceCure Medical Ltd., Minimax Medical Holding Group.

North America was the largest region in the interventional oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interventional oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the interventional oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The interventional oncology market consists of revenues earned by entities by providing services such as image-guided tumor ablation, biopsy and diagnostic imaging, pain palliation procedures, and thermal ablation planning and follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional oncology market also includes sales of image-guided navigation systems, catheters and guidewires, radiation delivery systems, and biopsy needles and systems. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Oncology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional oncology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional oncology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional oncology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Radiation Therapy Devices; Ablation Devices; Embolization Devices
  • 2) By Technology Type: Ultrasound; Computed Tomography Guided; Magnetic Resonance-Guided
  • 3) By Procedure: Tumor Ablation; Tumor Biopsy; Vascular Interventions; Palliative Care
  • 4) By Application Areas: Liver Cancer; Lung Cancer; Kidney Cancer; Pancreatic Cancer; Prostate Cancer
  • 5) By End-Users: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Research And Academic Institutions
  • Subsegments:
  • 1) By Radiation Therapy Devices: Linear Accelerators; Proton Therapy Systems; Brachytherapy Devices
  • 2) By Ablation Devices: Radiofrequency Ablation Devices; Microwave Ablation Devices; Cryoablation Devices; Irreversible Electroporation Systems
  • 3) By Embolization Devices: Microspheres; Coil Embolization Devices; Liquid Embolic Agents; Embolic Protection Devices
  • Companies Mentioned: Johnson & Johnson; Siemens Healthineers AG; Stryker Corporation; GE HealthCare Technologies Inc.; Boston Scientific Corporation; Terumo Corporation; Hologic Inc.; Teleflex Incorporated; Lantheus Holdings Inc.; Penumbra Inc.; Merit Medical Systems Inc.; Guerbet S.A; Asahi Intecc Co. Ltd.; AngioDynamics Inc.; Sirtex Medical Limited.; Delcath Systems Inc.; ABK Biomedical Inc.; Profound Medical Inc.; IceCure Medical Ltd.; Minimax Medical Holding Group
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Oncology Market Characteristics

3. Interventional Oncology Market Trends And Strategies

4. Interventional Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Interventional Oncology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Interventional Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Interventional Oncology Market Growth Rate Analysis
  • 5.4. Global Interventional Oncology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Interventional Oncology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Interventional Oncology Total Addressable Market (TAM)

6. Interventional Oncology Market Segmentation

  • 6.1. Global Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiation Therapy Devices
  • Ablation Devices
  • Embolization Devices
  • 6.2. Global Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ultrasound
  • Computed Tomography Guided
  • Magnetic Resonance-Guided
  • 6.3. Global Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tumor Ablation
  • Tumor Biopsy
  • Vascular Interventions
  • Palliative Care
  • 6.4. Global Interventional Oncology Market, Segmentation By Application Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • 6.5. Global Interventional Oncology Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research And Academic Institutions
  • 6.6. Global Interventional Oncology Market, Sub-Segmentation Of Radiation Therapy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Linear Accelerators
  • Proton Therapy Systems
  • Brachytherapy Devices
  • 6.7. Global Interventional Oncology Market, Sub-Segmentation Of Ablation Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Irreversible Electroporation Systems
  • 6.8. Global Interventional Oncology Market, Sub-Segmentation Of Embolization Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microspheres
  • Coil Embolization Devices
  • Liquid Embolic Agents
  • Embolic Protection Devices

7. Interventional Oncology Market Regional And Country Analysis

  • 7.1. Global Interventional Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Interventional Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Interventional Oncology Market

  • 8.1. Asia-Pacific Interventional Oncology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Interventional Oncology Market

  • 9.1. China Interventional Oncology Market Overview
  • 9.2. China Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Interventional Oncology Market

  • 10.1. India Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Interventional Oncology Market

  • 11.1. Japan Interventional Oncology Market Overview
  • 11.2. Japan Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Interventional Oncology Market

  • 12.1. Australia Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Interventional Oncology Market

  • 13.1. Indonesia Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Interventional Oncology Market

  • 14.1. South Korea Interventional Oncology Market Overview
  • 14.2. South Korea Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Interventional Oncology Market

  • 15.1. Western Europe Interventional Oncology Market Overview
  • 15.2. Western Europe Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Interventional Oncology Market

  • 16.1. UK Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Interventional Oncology Market

  • 17.1. Germany Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Interventional Oncology Market

  • 18.1. France Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Interventional Oncology Market

  • 19.1. Italy Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Interventional Oncology Market

  • 20.1. Spain Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Interventional Oncology Market

  • 21.1. Eastern Europe Interventional Oncology Market Overview
  • 21.2. Eastern Europe Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Interventional Oncology Market

  • 22.1. Russia Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Interventional Oncology Market

  • 23.1. North America Interventional Oncology Market Overview
  • 23.2. North America Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Interventional Oncology Market

  • 24.1. USA Interventional Oncology Market Overview
  • 24.2. USA Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Interventional Oncology Market

  • 25.1. Canada Interventional Oncology Market Overview
  • 25.2. Canada Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Interventional Oncology Market

  • 26.1. South America Interventional Oncology Market Overview
  • 26.2. South America Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Interventional Oncology Market

  • 27.1. Brazil Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Interventional Oncology Market

  • 28.1. Middle East Interventional Oncology Market Overview
  • 28.2. Middle East Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Interventional Oncology Market

  • 29.1. Africa Interventional Oncology Market Overview
  • 29.2. Africa Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Interventional Oncology Market Competitive Landscape And Company Profiles

  • 30.1. Interventional Oncology Market Competitive Landscape
  • 30.2. Interventional Oncology Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Interventional Oncology Market Other Major And Innovative Companies

  • 31.1. Terumo Corporation
  • 31.2. Hologic Inc.
  • 31.3. Teleflex Incorporated
  • 31.4. Lantheus Holdings Inc.
  • 31.5. Penumbra Inc.
  • 31.6. Merit Medical Systems Inc.
  • 31.7. Guerbet S.A
  • 31.8. Asahi Intecc Co. Ltd.
  • 31.9. AngioDynamics Inc.
  • 31.10. Sirtex Medical Limited.
  • 31.11. Delcath Systems Inc.
  • 31.12. ABK Biomedical Inc.
  • 31.13. Profound Medical Inc.
  • 31.14. IceCure Medical Ltd.
  • 31.15. Minimax Medical Holding Group

32. Global Interventional Oncology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Oncology Market

34. Recent Developments In The Interventional Oncology Market

35. Interventional Oncology Market High Potential Countries, Segments and Strategies

  • 35.1 Interventional Oncology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Interventional Oncology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Interventional Oncology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer